Cargando…
Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Periodicals, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754020/ https://www.ncbi.nlm.nih.gov/pubmed/34757698 http://dx.doi.org/10.1002/acr2.11363 |
| _version_ | 1784632191357026304 |
|---|---|
| author | Cappelli, Laura C. Darrah, Erika Shah, Ami A. Bingham, Clifton O. |
| author_facet | Cappelli, Laura C. Darrah, Erika Shah, Ami A. Bingham, Clifton O. |
| author_sort | Cappelli, Laura C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8754020 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wiley Periodicals, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87540202022-01-19 Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time Cappelli, Laura C. Darrah, Erika Shah, Ami A. Bingham, Clifton O. ACR Open Rheumatol Concise Communications Wiley Periodicals, Inc. 2021-11-10 /pmc/articles/PMC8754020/ /pubmed/34757698 http://dx.doi.org/10.1002/acr2.11363 Text en © 2021 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Concise Communications Cappelli, Laura C. Darrah, Erika Shah, Ami A. Bingham, Clifton O. Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time |
| title | Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time |
| title_full | Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time |
| title_fullStr | Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time |
| title_full_unstemmed | Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time |
| title_short | Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time |
| title_sort | patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time |
| topic | Concise Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754020/ https://www.ncbi.nlm.nih.gov/pubmed/34757698 http://dx.doi.org/10.1002/acr2.11363 |
| work_keys_str_mv | AT cappellilaurac patientswithcheckpointinhibitorinducedinflammatoryarthritisdonotbecomeseropositiveforanticycliccitrullinatedpeptidewhenfollowedovertime AT darraherika patientswithcheckpointinhibitorinducedinflammatoryarthritisdonotbecomeseropositiveforanticycliccitrullinatedpeptidewhenfollowedovertime AT shahamia patientswithcheckpointinhibitorinducedinflammatoryarthritisdonotbecomeseropositiveforanticycliccitrullinatedpeptidewhenfollowedovertime AT binghamcliftono patientswithcheckpointinhibitorinducedinflammatoryarthritisdonotbecomeseropositiveforanticycliccitrullinatedpeptidewhenfollowedovertime |